Pivotal study of KX-01 in patients with actinic keratosis
Phase of Trial: Phase III
Latest Information Update: 14 Aug 2017
At a glance
- Drugs KX 01 (Primary)
- Indications Actinic keratosis
- Focus Registrational; Therapeutic Use
- Sponsors Athenex
- 14 Aug 2017 Planned initiation date changed from 1 Oct 2016 to 1 Jul 2017, according to an Athenex media release.
- 17 Dec 2015 New trial record
- 15 Dec 2015 According to Athenex media release, company is planning to initiate this trial in the fourth quarter of 2016.